Nanalysis Scientific Corp. NSCIF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 66.27% | 54.15% | 58.85% | -35.71% | 10.34% |
| Total Depreciation and Amortization | 13.19% | 15.01% | 29.24% | -65.22% | -19.32% |
| Total Amortization of Deferred Charges | -45.49% | -45.49% | -68.33% | 22.02% | 0.37% |
| Total Other Non-Cash Items | -76.21% | -81.86% | -82.41% | 129.98% | 31.57% |
| Change in Net Operating Assets | 12,588.37% | -45.75% | 175.94% | 1,101.77% | -95.89% |
| Cash from Operations | 67.04% | -85.84% | 1.16% | 598.55% | 222.49% |
| Capital Expenditure | -32.03% | -348.01% | -387.68% | -2.93% | 14.78% |
| Sale of Property, Plant, and Equipment | -73.44% | -32.32% | -37.65% | 205.32% | 500.40% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 50.94% | 31.15% | 13.29% | 41.03% | 47.52% |
| Cash from Investing | 40.37% | 17.68% | -2.50% | 43.70% | 56.12% |
| Total Debt Issued | -100.31% | -- | -- | -52.72% | -60.07% |
| Total Debt Repaid | -31.86% | -48.80% | 4.87% | 64.73% | 61.42% |
| Issuance of Common Stock | 648.84% | -- | -43.15% | -91.07% | -91.07% |
| Repurchase of Common Stock | -- | -- | -- | -- | -1,900.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 24.61% | 6.89% | 14.48% | 50.21% | 49.26% |
| Cash from Financing | -91.49% | 120.16% | 121.30% | -101.95% | -187.11% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 119.74% | 98.26% | 193.32% | 118.83% | 80.06% |